Age-related prevalence of cross-reactive antibodies against influenza a(H3N2) variant virus, Germany, 2003 to 2010

Eurosurveillance

Volumn 20, Issue 32, 2015, Pages

  Blumel B ^a,b,c   Schweiger, B ^a   Dehnert, M ^a,d   Buda, S ^a   Reuss, A ^a   Czogiel, I ^a   Kamtsiuris, P ^a   Schlaud, M ^a   Poethko Muller C ^a   Thamm, M ^a   Haas, W ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF APPLIED SCIENCES WEIHENSTEPHAN TRIESDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; HEMAGGLUTININ; VIRUS ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CLUSTER ANALYSIS; ECOSYSTEM MONITORING; FEMALE; GENETIC VARIABILITY; GERMANY; HUMAN; INFLUENZA A (H3N2); INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; MALE; MIDDLE AGED; PREVALENCE; SEASONAL INFLUENZA; SENSITIVITY AND SPECIFICITY; VIRUS STRAIN; ADOLESCENT; AGE; AGED; ANIMAL; BLOOD; CHILD; CROSS REACTION; GENETICS; HEALTH SURVEY; HEMAGGLUTINATION INHIBITION TEST; IMMUNOLOGY; INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; PIG; PRESCHOOL CHILD; SWINE DISEASES; VACCINATION; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; FEMALE; GERMANY; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; SWINE; SWINE DISEASES; VACCINATION; YOUNG ADULT;

EID: 84939507623     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.es2015.20.32.21206     Document Type: Article

References (35)

1. Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: a review of the literature. Clin Infect Dis. 2007;44(8):1084-8. http://dx.doi.org/10.1086/512813 PMID:17366454
2. World Health Organization (WHO). Standardization of terminology for the influenza virus variants infecting humans: Update. Geneva: WHO; 2014. Available from: http://www.who.int/influenza/gisrs_laboratory/terminology_variant/en/
3. Centers for Disease Control and Prevention (CDC). Case count: detected U.S. human infections with H3N2v by state since August 2011. Atlanta: CDC; [Accessed 14 Sep 2014]. Available from: http://www.cdc.gov/flu/swineflu/h3n2v-case-count.htm
4. Jhung MA, Epperson S, Biggerstaff M, Allen D, Balish A, Barnes N, et al. Outbreak of variant influenza A(H3N2) virus in the United States. Clin Infect Dis. 2013;57(12):1703-12. http://dx.doi.org/10.1093/cid/cit649 PMID:24065322
5. Lina B, Bouscambert M, Enouf V, Rousset D, Valette M, van der Werf S. S-OtrH3N2 viruses: use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses. Euro Surveill. 2011;16(50):20039. PMID:22221493
6. Lindstrom S, Garten R, Balish A, Shu B, Emery S, Berman L, et al. Human infections with novel reassortant influenza A(H3N2)v viruses, United States, 2011. Emerg Infect Dis. 2012;18(5):834-7. http://dx.doi.org/10.3201/eid1805.111922 PMID:22516540
7. Centers for Disease Control and Prevention (CDC). Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccine on cross-reactive antibodies - United States. MMWR Morb Mortal Wkly Rep. 2012;61(14):237-41. PMID:22495226
8. Hoschler K, Thompson C, Casas I, Ellis J, Galiano M, Andrews N, et al. Population susceptibility to North American and Eurasian swine influenza viruses in England, at three time points between 2004 and 2011. Euro Surveill. 2013;18(36):20578. http://dx.doi.org/10.2807/1560-7917.ES2013.18.36.20578 PMID:24079379
9. Kishida N, Imai M, Xu H, Taya K, Fujisaki S, Takashita E, et al. Seroprevalence of a novel influenza A (H3N2) variant virus in the Japanese population. Jpn J Infect Dis. 2013;66(6):549-51. http://dx.doi.org/10.7883/yoken.66.549 PMID:24270150
10. Skowronski DM, Janjua NZ, De Serres G, Purych D, Gilca V, Scheifele DW, et al. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). J Infect Dis. 2012;206(12):1852-61. http://dx.doi.org/10.1093/infdis/jis500 PMID:22872731
11. Waalen K, Kilander A, Dudman SG, Ramos-Ocao R, Hungnes O. Age-dependent prevalence of antibodies cross-reactive to the influenza A(H3N2) variant virus in sera collected in Norway in 2011. Euro Surveill. 2012;17(19):20170. PMID:22607964
12. European Centre for Disease Prevention and Control (ECDC). Update - Swine-origin triple reassortant influenza A(H3N2) variant viruses in North America. Risk assessment. Stockholm: ECDC; 2012. Available from: http://www.ecdc.europa.eu/en/publications/publications/1208-ter-rapid-risk-assessmentinfluenza-ah3n2-us.pdf
13. Dudareva S, Schweiger B, Thamm M, Höhle M, Stark K, Krause G, et al. Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre- and postpandemic period. PLoS ONE. 2011;6(6):e21340. http://dx.doi.org/10.1371/journal.pone.0021340 PMID:21701598
14. Scheidt-Nave C, Kamtsiuris P, Gößwald A, Hölling H, Lange M, Busch MA, et al. German health interview and examination survey for adults (DEGS) - design, objectives and implementation of the first data collection wave. BMC Public Health. 2012;12(1):730. http://dx.doi.org/10.1186/1471-2458-12-730 PMID:22938722
15. Kurth BM, Kamtsiuris P, Hölling H, Schlaud M, Dölle R, Ellert U, et al. The challenge of comprehensively mapping children’s health in a nation-wide health survey: design of the German KiGGS-Study. BMC Public Health. 2008;8(1):196. http://dx.doi.org/10.1186/1471-2458-8-196 PMID:18533019
16. Robert Koch Institute (RKI). Bericht zur Epidemiologie der Influenza in Deutschland, Saison 2011/12. [Report on the epidemiology of influenza in Germany, season 2011/12]. Berlin: RKI; 2012. ISBN 978-3-89606-247-5. German. Available from: https://influenza.rki.de/Saisonberichte/2011.pdf
17. Katz JM, Hancock K, Xu X. Serologic assays for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev Anti Infect Ther. 2011;9(6):669-83. http://dx.doi.org/10.1586/eri.11.51 PMID:21692672
18. Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3(1):17. http://dx.doi.org/10.1186/1751-0473-3-17 PMID:19087314
19. Ma J, Dushoff J, Earn DJ. Age-specific mortality risk from pandemic influenza. J Theor Biol. 2011;288:29-34. http://dx.doi.org/10.1016/j.jtbi.2011.08.003 PMID:21856313
20. Kucharski AJ, Gog JR. The role of social contacts and original antigenic sin in shaping the age pattern of immunity to seasonal influenza. PLOS Comput Biol. 2012;8(10):e1002741. http://dx.doi.org/10.1371/journal.pcbi.1002741 PMID:23133346
21. Klein SL, Pekosz A. Sex-based biology and the rational design of influenza vaccination strategies. J Infect Dis. 2014;209(Suppl 3):S114-9. http://dx.doi.org/10.1093/infdis/jiu066 PMID:24966191
22. Gilbert GL, Cretikos MA, Hueston L, Doukas G, O’Toole B, Dwyer DE. Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS ONE. 2010;5(9):e12562. http://dx.doi.org/10.1371/journal.pone.0012562 PMID:20830210
23. Ikonen N, Strengell M, Kinnunen L, Osterlund P, Pirhonen J, Broman M, et al. High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill. 2010;15(5):19478. PMID:20144443
24. Skowronski DM, Hottes TS, McElhaney JE, Janjua NZ, Sabaiduc S, Chan T, et al. Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. J Infect Dis. 2011;203(2):158-67. http://dx.doi.org/10.1093/infdis/jiq039 PMID:21288814
25. Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W, et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med. 2013;19(10):1305-12. http://dx.doi.org/10.1038/nm.3350 PMID:24056771
26. van de Sandt CE, Kreijtz JH, de Mutsert G, Geelhoed-Mieras MM, Hillaire ML, Vogelzang-van Trierum SE, et al. Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus. J Virol. 2014;88(3):1684-93. http://dx.doi.org/10.1128/JVI.02843-13 PMID:24257602
27. Rosella LC, Groenwold RH, Crowcroft NS. Assessing the impact of confounding (measured and unmeasured) in a case-control study to examine the increased risk of pandemic A/H1N1 associated with receipt of the 2008-9 seasonal influenza vaccine. Vaccine. 2011;29(49):9194-200. http://dx.doi.org/10.1016/j.vaccine.2011.09.132 PMID:22001885
28. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med. 2010;7(4):e1000258. http://dx.doi.org/10.1371/journal.pmed.1000258 PMID:20386731
29. Viboud C, Simonsen L. Does seasonal influenza vaccination increase the risk of illness with the 2009 A/H1N1 pandemic virus? PLoS Med. 2010;7(4):e1000259. http://dx.doi.org/10.1371/journal.pmed.1000259 PMID:20386730
30. Skowronski DM, Hamelin ME, De Serres G, Janjua NZ, Li G, Sabaiduc S, et al. Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk. PLoS ONE. 2014;9(1):e86555. http://dx.doi.org/10.1371/journal.pone.0086555 PMID:24475142
31. Houser KV, Katz JM, Tumpey TM. Seasonal trivalent inactivated influenza vaccine does not protect against newly emerging variants of influenza A (H3N2v) virus in ferrets. J Virol. 2013;87(2):1261-3. http://dx.doi.org/10.1128/JVI.02625-12 PMID:23115290
32. Black S, Nicolay U, Vesikari T, Knuf M, Del Giudice G, Della Cioppa G, et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J. 2011;30(12):1081-5. http://dx.doi.org/10.1097/INF.0b013e3182367662 PMID:21983214
33. Ng S, Fang VJ, Ip DKM, Chan KH, Leung GM, Peiris JSM, et al. Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children. J Infect Dis. 2013;208(8):1320-4. http://dx.doi.org/10.1093/infdis/jit372 PMID:23908481
34. Reber A, Katz J. Immunological assessment of influenza vaccines and immune correlates of protection. Expert Rev Vaccines. 2013;12(5):519-36. http://dx.doi.org/10.1586/erv.13.35 PMID:23659300
35. Wallinga J, Teunis P, Kretzschmar M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol. 2006;164(10): 936-44. http://dx.doi.org/10.1093/aje/kwj317 PMID:16968863